Metro Infectious Diseases Consultants L.L.C. ( Site 5653) — Decatur, Georgia

Metro Infectious Diseases Consultants L.L.C. ( Site 5653) is a clinical research site located in Decatur, Georgia, United States 30033.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Metro Infectious Diseases Consultants L.L.C. ( Site 5653) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HIV-1 Infection.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro Infectious Diseases Consultants L.L.C. ( Site 5653)?

Metro Infectious Diseases Consultants L.L.C. ( Site 5653) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro Infectious Diseases Consultants L.L.C. ( Site 5653) conducted?

Metro Infectious Diseases Consultants L.L.C. ( Site 5653) has 1 clinical trials on record, with 1 currently active. Their work covers HIV-1 Infection.

Is Metro Infectious Diseases Consultants L.L.C. ( Site 5653) accredited by Crixeo Health?

Metro Infectious Diseases Consultants L.L.C. ( Site 5653) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Metro Infectious Diseases Consultants L.L.C. ( Site 5653)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.